Standard Biotools (LAB) EBIAT (2016 - 2025)
Historic EBIAT for Standard Biotools (LAB) over the last 16 years, with Q3 2025 value amounting to -$34.7 million.
- Standard Biotools' EBIAT fell 2876.61% to -$34.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$128.3 million, marking a year-over-year decrease of 293.93%. This contributed to the annual value of -$138.9 million for FY2024, which is 8603.33% down from last year.
- As of Q3 2025, Standard Biotools' EBIAT stood at -$34.7 million, which was down 2876.61% from -$33.5 million recorded in Q2 2025.
- Standard Biotools' EBIAT's 5-year high stood at -$9.4 million during Q4 2021, with a 5-year trough of -$76.3 million in Q1 2022.
- In the last 5 years, Standard Biotools' EBIAT had a median value of -$26.0 million in 2025 and averaged -$29.3 million.
- Per our database at Business Quant, Standard Biotools' EBIAT crashed by 30533.45% in 2022 and then skyrocketed by 7792.18% in 2023.
- Standard Biotools' EBIAT (Quarter) stood at -$9.4 million in 2021, then tumbled by 121.07% to -$20.8 million in 2022, then grew by 5.13% to -$19.8 million in 2023, then plummeted by 72.29% to -$34.1 million in 2024, then fell by 1.81% to -$34.7 million in 2025.
- Its EBIAT was -$34.7 million in Q3 2025, compared to -$33.5 million in Q2 2025 and -$26.0 million in Q1 2025.